[The COMPASS study]

G Ital Cardiol (Rome). 2018 Jan;19(1):1-7. doi: 10.1714/2852.28773.
[Article in Italian]
No abstract available

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / pathology
  • Double-Blind Method
  • Drug Therapy, Combination
  • Factor Xa Inhibitors / administration & dosage
  • Factor Xa Inhibitors / adverse effects
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Follow-Up Studies
  • Humans
  • Rivaroxaban / administration & dosage*
  • Rivaroxaban / adverse effects
  • Treatment Outcome
  • Vascular Diseases / drug therapy*
  • Vascular Diseases / pathology

Substances

  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Rivaroxaban
  • Aspirin